Jeffrey S. Ervin
Chief Financial OfficerMr. Jeffrey S. Ervin, also known as Jeff, is Chief Financial Officer of Allarity Therapeutics, Inc. from July 2025. He is Chief Financial Officer of Allarity Acquisition Corp. Mr. Ervin served as Vice President of Investor Relations at DDC Enterprise Limited until July 2025. He served as Chief Financial Officer at DDC Enterprise Limited until February 1, 2025 and serves as its Vice President of Investor Relations since February 01, 2025. Mr. Ervin is CEO of Sanaregen Vision Therapeutics, Inc., since February 2025. He was Co-Chief Financial Officer of DDC Enterprise Limited from June 25, 2024. He is to leverage his background in U.S. capital markets to oversee financial controls, reporting requirements and aid in investor engagement for DayDayCook. He is Co-founder of IMAC Holdings Inc and had been the Chairman and Director of IMAC Holdings, Inc. since 2018 until May 24, 2024 and served as its Chief Executive Officer since 2015 until May 24, 2024. He served as Independent Director at Cingulate Inc. since February 2024 until July 9, 2026. Mr. Ervin Co-Founded IMAC Holdings in March 2015. Mr. Ervin was the Senior Financial Analyst and Vice President of Finance for the Baptist Hospital System of Nashville from 2006 to September 2011, responsible for sourcing and managing direct investments to satisfy pension obligations. After these five years, Mr. Ervin joined Medicare.com parent Medx Publishing in October 2011 as the senior financial officer tasked with building administrative functions to satisfy rapid growth in the CMS education sector. During this time through March 2015, Medicare.com earned INC. 500 recognition and he was instrumental in the acquisition of Medicaid.com, which was sold to United Healthcare Group. Mr. Ervin was also responsible for the disposition and ultimate sale of Medicare.com to eHealth Insurance. Mr. Ervin earned his M.B.A. from Owen School of Management at Vanderbilt University and a Bachelor of Science in Finance from Miami University.
Positions
- Company NameAllarity Therapeutics, Inc.Stock CodeALLRPositionChief Financial OfficerColleagues
- THThomas H. JensenFounder, CEO & Director
- GWGerald W. McLaughlinIndependent Chairman of the Board
- JRJeremy R. GraffPresident & Chief Development Officer
- SMSteen Meier KnudsenFounder & Chief Scientific Officer
- JLJose L. IglesiasConsultant Chief Medical Officer
- DDDaniel Douglas Von HoffMember of Scientific Advisory Board
- UAUrsula A. MatulonisMember of Scientific Advisory Board
- JAJoyce Ann O'ShaughnessyMember of Scientific Advisory Board
